When cholesterol meets histamine, it gives rise to dendrogenin A: a tumour suppressor metabolite1

Abstract : Dendrogenin A (DDA) is the first steroidal alkaloid (SA) to be identified in human tissues to date and arises from the stereoselective enzymatic conjugation of 5,6α-epoxycholesterol (5,6α-EC) with histamine (HA). DDA induces the re-differentiation of cancer cellsin vitroandin vivoand prevents breast cancer (BC) and melanoma development in mice, evidencing its protective role against oncogenesis. In addition, DDA production is lower in BCs compared with normal tissues, suggesting a deregulation of its biosynthesis during carcinogenesis. The discovery of DDA reveals the existence of a new metabolic pathway in mammals which lies at the crossroads of cholesterol and HA metabolism and which leads to the production of this metabolic tumour suppressor.
Complete list of metadatas

Cited literature [56 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02380631
Contributor : Marc Poirot <>
Submitted on : Tuesday, November 26, 2019 - 12:26:25 PM
Last modification on : Wednesday, November 27, 2019 - 1:40:23 AM

Identifiers

Collections

Citation

Marc Poirot, Sandrine Silvente-Poirot. When cholesterol meets histamine, it gives rise to dendrogenin A: a tumour suppressor metabolite1. Biochemical Society Transactions, Portland Press, 2016, 44 (2), pp.631-637. ⟨10.1042/BST20150232⟩. ⟨inserm-02380631⟩

Share

Metrics

Record views

30

Files downloads

17